AparnaBio recently launched InVivoPlex-Tumor, a tumor-targeted nanoparticle reagent for the delivery of RNAi payloads to mouse models of cancer.
The reagent targets the leaky blood vessels of tumors, minimizing RNAi activity at non-target tissues and organs, according to the company.
Bioo Scientific has introduced the Air small RNA sequencing kit for the preparation of Illumina-compatible small RNA sequencing libraries.
It has been optimized for sample multiplexing using the Air barcoded adapters, and includes Air Ligase, an enhanced enzyme that allows greater sequencing coverage than currently available T4 RNA ligases, according to the company.
Qiagen has introduced the MiScript Target Protector, which specifically interferes with the interaction of an miRNA with a single target, leaving the regulation of other targets of the same miRNA unaffected.
The company has also launched FlexiTube siRNA Premix, in which siRNA and transfection reagents are premixed at optimized ratios, which shortens the transfection protocol and enables consistency.